First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2026 revenue reaching $57M — +48.4% growth in a single year.
What Moves the Stock
1Defense contract awards and renewals: Wins with prime contractors (Lockheed Martin, BAE Systems, Elbit) for F-35 helmet displays, soldier systems, or next-gen weapon sights drive multi-year revenue visibility
2Consumer AR/VR design wins: Announcements of component selection by major OEMs (Meta, Apple, Microsoft) for headset programs create significant valuation expansion despite uncertain production timelines
3Quarterly revenue volatility: Lumpy defense deliveries and prototype shipment timing create 20-30% quarter-over-quarter revenue swings that drive stock reactions
4Cash burn rate and financing needs: With negative free cash flow, announcements of equity raises, debt facilities, or strategic investments impact dilution concerns
5Defense & Military Systems: Microdisplays and optics for helmet-mounted displays, weapon sights, and night vision systems (estimated 50-60% of revenue)
6Industrial Applications: Displays for thermal imaging, medical devices, and enterprise AR headsets (estimated 25-35%)
7Consumer Electronics: Components for AR/VR headsets and wearable devices (estimated 10-20%, highly variable)
Watch on earnings: US defense budget allocation to soldier systems and aviation modernization programs (impacts F-35, IVAS, and next-gen helmet display funding), Global AR/VR headset shipment volumes and ASP trends (indicates market size for consumer microdisplay opportunity), Quarterly defense backlog and book-to-bill ratio (forward revenue visibility indicator).
One Sentence Summary:
Kopin: the story is balanced — defense contract awards and renewals: wins with prime contractors (lockheed martin, bae systems, elbit) for f-35 helmet displays.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.